GSK India Head Admits Firm Seeking New Partners
This article was originally published in PharmAsia News
Executive SummaryIndia's GlaxoSmithKline Pharmaceuticals acknowledges it is on the lookout for local acquisitions to take advantage of its huge cash surplus. GSK India Senior Executive Director Mernosh Kapadia said the firm seeks to expand its India business, partially confirming the rumored interest in its parent GSK to acquire India's Piramal. GSK India already is the largest foreign-owned drug maker in India, so its acquisition plans are of great interest. (Click here for more
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.